Acta Dermato Venereologica · 2013 · 66 citations · 20 references
MedicineOncologyPathologyCutaneous OncologyMetastasisNeoplasiaCancer Survival AnalysisLocal RecurrenceMalignant NeoplasmsMalignant TumorsSkin TumorsSquamous Cell CarcinomaHistopathological GradingLocal Tumor RecurrenceMetastatic Cutaneous Squamous Cell CarcinomaPrognosis Of Cutaneous MetastasesPrognostic Factors AnalysisRecurrence-free SurvivalSquamous Cell Carcinoma HistopathologyUnivariate Analysis
Cutaneous squamous cell carcinomas (cSCC) can recur locally and can metastasize. The objective of this study was to identify clinical and histopathological prognostic factors for local recurrence and metastasis in cSCCs at any body site. Clinical and histopathological data were collected from 224 patients with cSCC. During the median follow-up period of 43 months (range 0-73 months) the cumulative probabilities of recurrence-free survival at 1, 2 and 4 years post-treatment were 98.0%, 96.9% and 94.7%, respectively, and for metastasis-free survival 98.1%, 97.0% and 95.9%, respectively. In univariate survival analyses, predictors for local recurrence were every millimetre increase in tumour diameter and in tumour thickness. Predictors for metastasis this was location on the ear, invasion of deeper structures, no surgical treatment, poor differentiation, every millimetre increase in tumour diameter and in tumour thickness. In multivariate survival analysis, every millimetre increase in both tumour diameter and tumour thickness were independent predictors for local recurrence as well as for metastasis and, therefore, it is important to report these in patients' files. Defining prognostic valuables is important for diagnostic work-up, treatment and follow-up for an individual patient.
20
Measurement of Observer Agreement
Harold L. Kundel, Marcia Polansky · Radiology · 2003 · 1.5K citations
Mortality Risk From Squamous Cell Skin Cancer
Gary L. Clayman, F. Christopher Holsinger, Xian Zhou et al. · Journal of Clinical Oncology · 2005 · 392 citations